Mark Shephard

Screening for chronic kidney disease in Australia: a pilot study in the community and workplace

Timothy H. Mathew, Olivia Corso, Marie Ludlow et al. · Kidney International · 2010 · 74 citations · Full text

Glomerulonephritis, Hemodialysis, Urology +12

Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities

Tomer Shemesh, Kevin Rowley, Mark Shephard et al. · Clinica Chimica Acta · 2006 · 69 citations

Point-of-care Testing, Bayer Dca2000+, On-site Pathology +5

The impact of point of care testing on diabetes services along Victoria's Mallee Track: Results of a community-based diabetes risk assessment and management program

Mark Shephard, Beryl Mazzachi, Anne Shephard et al. · Rural and Remote Health · 2005 · 62 citations · Full text

Comparative performance of two point-of-care analysers for lipid testing.

Mark Shephard, Beryl Mazzachi, Anne Shephard · PubMed · 2007 · 51 citations

Lipid Analysis, Point-of-care Testing, Hyperlipidemia +20

Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen

Mark Shephard, M.J. Whiting · Clinical Chemistry · 1990 · 50 citations